Compare · CUVL vs DXST
CUVL vs DXST
Side-by-side comparison of Clinuvel Pharmaceuticals Limited (CUVL) and Decent Holding Inc (DXST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CUVL and DXST operate in Miscellaneous (Industrials), so they compete in similar markets.
- CUVL is the larger of the two at $247.1M, about 163.8x DXST ($1.5M).
- DXST has hit the wire 4 times in the past 4 weeks while CUVL has been quiet.
- Company
- Clinuvel Pharmaceuticals Limited
- Decent Holding Inc
- Price
- -
- -
- Market cap
- $247.1M
- $1.5M
- 1M return
- -
- -45.95%
- 1Y return
- -
- -98.36%
- Industry
- Miscellaneous
- Miscellaneous
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 0
- 4
- Recent ratings
- 0
- 0
CUVL
Clinuvel Pharmaceuticals Limited
CLINUVEL is a global biopharmaceutical company focused on developing and delivering innovative therapies for patients with genetic, metabolic, and dermatological disorders. The Company's portfolio is centred around melanocortin peptides, with programs advancing in photomedicine and vitiligo. CLINUVEL is listed on the Australian Securities Exchange (ASX: CUV) and the Nasdaq Stock Market (Nasdaq: CUVL).
Latest CUVL
No recent items for Clinuvel Pharmaceuticals Limited.
Latest DXST
- SEC Form 6-K filed by Decent Holding Inc
- Decent Holding Outlines Plans to Expand Suncare’s Health and Wellness Product Offerings
- SEC Form S-8 filed by Decent Holding Inc
- SEC Form 6-K filed by Decent Holding Inc
- SEC Form F-3 filed by Decent Holding Inc
- SEC Form 6-K filed by Decent Holding Inc
- Decent Holding Reports Approximately $3 Million in Senior Care Service-Related Cash Collections Since September 2026
- SEC Form 6-K filed by Decent Holding Inc
- Decent Holding Plans Initial Deployment of Up to 3,000 Taihao Intelligent Health Management Robots at Selected Senior-Care Operation-Centers
- SEC Form 6-K filed by Decent Holding Inc